HomeCompareGZPHF vs CHD

GZPHF vs CHD: Dividend Comparison 2026

GZPHF yields 4.78% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GZPHF wins by $75.9K in total portfolio value
10 years
GZPHF
GZPHF
● Live price
4.78%
Share price
$2.34
Annual div
$0.11
5Y div CAGR
32.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.2K
Annual income
$29,184.44
Full GZPHF calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — GZPHF vs CHD

📍 GZPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGZPHFCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GZPHF + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GZPHF pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GZPHF
Annual income on $10K today (after 15% tax)
$406.66/yr
After 10yr DRIP, annual income (after tax)
$24,806.77/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, GZPHF beats the other by $23,708.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GZPHF + CHD for your $10,000?

GZPHF: 50%CHD: 50%
100% CHD50/50100% GZPHF
Portfolio after 10yr
$64.3K
Annual income
$15,238.47/yr
Blended yield
23.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

GZPHF
No analyst data
Altman Z
2.4
Piotroski
4/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GZPHF buys
0
CHD buys
0
No recent congressional trades found for GZPHF or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGZPHFCHD
Forward yield4.78%1.27%
Annual dividend / share$0.11$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR32.3%23.1%
Portfolio after 10y$102.2K$26.4K
Annual income after 10y$29,184.44$1,292.51
Total dividends collected$73.4K$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: GZPHF vs CHD ($10,000, DRIP)

YearGZPHF PortfolioGZPHF Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$11,333$632.95$10,856$156.32+$477.00GZPHF
2$13,013$886.93$11,811$195.24+$1.2KGZPHF
3$15,183$1,259.23$12,883$244.38+$2.3KGZPHF
4$18,063$1,816.62$14,091$306.64+$4.0KGZPHF
5$21,999$2,672.13$15,463$385.88+$6.5KGZPHF
6$27,563$4,023.99$17,033$487.17+$10.5KGZPHF
7$35,726$6,233.83$18,843$617.36+$16.9KGZPHF
8$48,218$9,990.59$20,947$785.72+$27.3KGZPHF
9$68,265$16,671.91$23,419$1,004.91+$44.8KGZPHF
10$102,228$29,184.44$26,350$1,292.51+$75.9KGZPHF

GZPHF vs CHD: Complete Analysis 2026

GZPHFStock

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. It is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, tablets, capsules, lozenges, injections, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2021, it had 154 retail chain pharmacy outlets, which included 22 Cai Zhi Lin pharmacy outlets, 36 Jian Min pharmacy outlets, 51 GPC Prescription Pharmacy outlets, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd outlets, as well as 22 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Full GZPHF Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this GZPHF vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GZPHF vs SCHDGZPHF vs JEPIGZPHF vs OGZPHF vs KOGZPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.